Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors

We report the cases of two patients with secondary hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors, who were diagnosed using the recently developed HScore. The first patient presented with fever, cytopenia, and elevated liver enzyme levels at 46 days post‐pembrolizumab admi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurozumi, Atsumasa, Takahashi, Hidenori, Watanabe, Takayasu, Iwasaki, Yoshinobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107030/
https://www.ncbi.nlm.nih.gov/pubmed/33783978
http://dx.doi.org/10.1111/1759-7714.13954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107030/
https://www.ncbi.nlm.nih.gov/pubmed/33783978
http://dx.doi.org/10.1111/1759-7714.13954

Ejemplares similares